Bruce I. Sachs, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,300 shares at $63.10 ($542K) on 2013-11-20, disclosed to the SEC on 2013-11-21.
Scheduled sale ($542k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.10 | 700 | $44K | 8.2% |
| 2 | $64.21 | 800 | $51K | 9.5% |
| 3 | $65.35 | 4,900 | $320K | 59.1% |
| 4 | $66.25 | 1,700 | $113K | 20.8% |
| 5 | $67.15 | 200 | $13K | 2.5% |
| Total | $65.28 avg | 8,300 |
| $542K |
| 100% |
| Filing → |
| VRTX | SELL | 2024-05-24 | $3.2M | — | Filing → |
| VRTX | SELL | 2023-11-08 | $4.3M | — | Filing → |
| VRTX | SELL | 2023-07-18 | $8.0M | — | Filing → |